课题基金 / 基金详情

Analysis of molecular mechanisms in leukemogenesis by chimeric transcription factors

Analysis of molecular mechanisms in leukemogenesis by chimeric transcription factors
嵌合转录因子分析白血病发生的分子机制
批准号:
11470208
负责人:
NAKAMURA Yuichi
金额:
$6.98万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

NAKAMURA Yuichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
AML1/EVI-1 is a chimeric transcription factor that plays a causative role in blastic transformation of chronic myelogenous leukemia (CML) and myelodysplastic syndrome (MDS). AML1/EVI-1 repressed transcription through PAI-1 promoter that was activated by TGFβ signals. AML1/EVI-1 specifically bound to an intracellular signal transducer of TGFβ Smad-3, and inhibited its functions. Because AML1/EVI-1 bound to a corepressor CtBP, recruitment of histone deacetylase could be an underlying mechanism. AML1/EVI-1 blocked differentiation of 32D cells induced by G-CSF, depending on the CtBP-binding region in the EVI-1 portion. These data indicate that AML1/EVI-1 progresses CML or MDS to acute leukemia partly through abolishing TGFβ signals. On the other hand, EVI-1 bound to JNK through the 1st zinc finger domain and inhibited its kinase activities stimulated by several cellular stresses including UV. EVI-1 protected 3T cells from apoptosis depending on the 1st zinc finger domain. Therefore, blocking JNK-mediated apoptosis could be another mechanism in development of leukemia by AML1/EVI-1.MLL/MEN (also termed as ELL) is a leukemia-related fusion protein found in acute myeloid leukemia or MDS-derived leukemia. Because MEN is an RNA polymerase factor, MLL/MEN is also a chimeric transcription factor. Both MEN and MLL/MEN bound to p53 and repressed its transcriptional abilities through the p53-binding sites. MEN was found to bind to p53 through the N-terminal portion and inhibit its transcription through the p53-binding sites. MEN stimulated growth of Rat1 cells in a semi-solid agar depending of p53-binding or repressing domain. Overexpression or aberrant expression of MEN may play an important role in development of myeloid leukemia. We generated knockout mice of MEN. They were embryonic lethal, and die before E6.5 and after implantation. MEN should play a non-redundant role as an elongation factor in postimplantation development of mice.
期刊论文(84)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Waga, K.: "Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells."Oncogene. 22. 59-68 (2003)
Waga, K.:“白血病相关转录因子 TEL 加速 Friend 红白血病细胞的分化。”癌基因。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakamura, F.: "Monocytic leukemia with CALM/AF10 rearrangement showing mediastinal emphysema."Am J Hematol. 72. 138-142 (2003)
Nakamura, F.:“单核细胞白血病伴 CALM/AF10 重排,显示纵隔气肿。”Am J Hematol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamagata, T., Mitani, K., Oda, H., Suzuki, T., Honda, H., Asai, T., Maki, K., Nakamoto, T., Hirai, H.: "Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organ."EMBO J. 19. 4676-4687 (2000)
山形,T.,三谷,K.,小田,H.,铃木,T.,本田,H.,浅井,T.,真木,K.,中本,T.,平井,H.:“GATA-的乙酰化-
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
57
    Analysis of feeling of material and operation induced by expectation and its application to artifacts design
    • 批准号:
      17K19976
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $4.16万
    • 财政年份:
      2017
    • 负责人:
      NAKAMURA Yuichi
    • 依托单位:
    Kinesiological analysis of gentle touch and design of intelligent communication
    • 批准号:
      15K12080
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2015
    • 负责人:
      NAKAMURA Yuichi
    • 依托单位:
    Record, Analysis, and Detection of Episodic Memory Oblivion using Wearable Lifelog
    • 批准号:
      25540082
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2013
    • 负责人:
      NAKAMURA Yuichi
    • 依托单位:
    Development of a New Impact High Pressure Apparatus and Rheological Evaluations of Lubricating Oils under Dynamic Compression
    • 批准号:
      23560160
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2011
    • 负责人:
      NAKAMURA Yuichi
    • 依托单位:
    国内基金
    海外基金
    EVI-1诱导miR-124甲基化通过RAS/ERK通路调控AML发生发展的机制研究
    • 批准号:
      82000148
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      郎雯竞
    • 依托单位:
    EVI-1/NM IIA/MG53通路在急性肾小管损伤中的作用研究
    • 批准号:
      81700604
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      于晓文
    • 依托单位:
    Evi-1、microRNA和DNA甲基化的调控环路异常导致白血病预后不良的机制研究
    • 批准号:
      81170517
    • 项目类别:
      面上项目
    • 资助金额:
      14.0万元
    • 批准年份:
      2011
    • 负责人:
      王莉莉
    • 依托单位: